This content is current only at the time of printing. This document was printed on 19 May 2022. A current copy is located at https://apvma.gov.au/node/93396
You are here
Trade Advice Notice on tulathromycin in Draxxin Injectable Solution for use on sheep
This consultation closed on 1 December 2021.
The Australian Pesticides and Veterinary Medicines Authority (APVMA) invites comment on the proposed use of tulathromycin in the product Draxxin Injectable Solution for use on sheep.
We invite written comment from 3 November 2021 to 1 December 2021 on the trade implications of this proposal.
The APVMA is able to consider comments relating to the legislative grounds for the assessment, which are the trade implications of the use of the product. The Trade Advice Notice provides a summary of the APVMA's residue and trade assessment.
Please note: submissions will be published on the APVMA’s website, unless you have asked for the submission to remain confidential, or if the APVMA chooses at its discretion not to publish any submissions received (refer to the public consultation coversheet).
Please lodge your submission using the public consultation coversheet, which provides options for how your submission will be published.
Note that all APVMA documents are subject to the access provisions of the Freedom of Information Act 1982 and may be required to be released under that Act should a request for access be made.
Please send your written submission and coversheet by email or post to:
Executive Director, Risk Assessment Capability
Australian Pesticides and Veterinary Medicines Authority
GPO Box 3262
Sydney NSW 2001